Quadrise Fuels Intnl

Update on bioMSART Testing

RNS Number : 2256I
Quadrise Fuels International PLC
11 August 2021
 

11 August 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Update on bioMSAR™ Testing

 

Quadrise , the supplier of MSAR®and bioMSAR  emulsion technology and fuels, which are low-cost, cleaner alternatives to heavy fuel oil and biofuels, is pleased to provide an update on the testing of bioMSAR™ on a medium speed 4-stroke Wärtsilä diesel engine at the VTT facility in Finland and the planned performance and emissions testing with Aquafuel.

 

bioMSAR™ Testing at VTT

 

A comprehensive suite of tests has been completed on a Wärtsilä 4-stroke engine using 5mt of bioMSAR™ fuel produced at QRF .  This engine was the same generic type previously used for MSAR® testing, though it has since been modified for dual fuel operation, and this required further work to enable comparison with the earlier MSAR® test results.  

 

The final bioMSAR™   test results show the following versus conventional liquid fuels:

 

· Greater than expected calculated CO2 savings - with reductions of 26-28%.

· Engine efficiency increased by up to 7%.

· Highly efficient combustion evidenced by low NOx, CO, particulate and soot emissions.

 

The CO2 savings delivered by existing biofuels are more typically in the region of 10-15%.  bioMSARTM 's  formulation can be adjusted to provide the consumers' required CO2 savings at the lowest cost.

 

The results of the test have been shared with MSC and an update on the MSC trial programme will be provided, as appropriate, in due course. 

 

Further Testing at Aquafuel

 

Following the successful initial tests reported in February 2021, modifications were carried out by Aquafuel on our Cummins 4-stroke, high-speed diesel engine generating set to allow very accurate performance monitoring, optimisation and measurements to be made.

 

These modifications are now complete and the further bioMSAR™ testing to optimise emissions and engine performance will be carried out at Aquafuel, commencing later this month.  Quadrise will be attending the tests at the Aquafuel site and some of this work will be included in the final segment of filming for Quadrise's contribution to the UK Chamber of Shipping's "Making Waves: The Future of Shipping" programme, to be launched on 13 September as part of London International Shipping Week. 

 

We expect the results of further testing at Aquafuel to be available by the end of September.   

 

 

Mike Kirk, Chairman of Quadrise, said:

 

"We are very pleased to share the positive bioMSAR™ test results - especially those relating to CO2 reductions and higher efficiencies.  Quadrise is making great progress on bioMSAR™ testing and development.  This work is crucial in enabling Quadrise to offer customers a lower cost renewable fuel solution, alongside our existing MSAR® fuel, and we look forward to sharing further information with shareholders during Q3 2021.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

For further information, please contact:

Quadrise Fuels International Plc


Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

[email protected]



Nominated Adviser


Cenkos Securities plc


Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900



Joint Brokers


Peel Hunt LLP


Richard Crichton

+44 (0)20 7418 8900

David McKeown




Shore Capital Stockbrokers Limited


Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

Public & Investor Relations


FTI Consulting


Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi


 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDIBUBDGBG